Bottom line
Is MMSCX a good fund? The bottom line
MMSCX is a share class of Praxis Small Cap Index Fund, an index small-cap mutual fund from Praxis.
Its expense ratio is 0.94% — about $94 a year on every $10,000 invested, cheaper than 57% of small-cap funds we track.
It returned +0.6% over one year, +4.9% a year over five years, +6.4% a year over ten (as of Dec 31, 2025, per its prospectus).
With $234 million in net assets and 717 holdings, its largest position is N/a (19.2%) and the top 10 make up 23.4% of the portfolio.
This share class carries a front-end sales charge of up to 5.25%; a no-load class or ETF alternative can avoid it.
What stands out
- Broadly diversified (717 holdings)
What to watch
- Front-end sales load up to 5.25%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What MMSCX invests in
The Praxis Small Cap Index Fund seeks to maximize long-term capital appreciation.
The Fund invests primarily in U.S. equity securities and seeks to reflect the performance of the U.S. small capitalization equities market, as measured by the CRSP U.S. Small Cap Index, its benchmark index. Under normal circumstances, the Fund invests at least 80 percent of the value of its assets in securities of, and investments related to, issuers in the Funds benchmark index. Typically, the Fund invests substantially more than 80 percent of the value of its assets in securities of issuers in its benchmark index. The Fund seeks to invest in companies aligned with the Praxis Stewardship Investing core values The Adviser does this by applying proprietary screens that reflect the Praxis Stewardship Investing core values. In addition, the Adviser uses optimization techniques to select securities according to their contribution to the Funds overall objective, while seeking to replicate…
From the fund's prospectus (filed Apr 20, 2026).
MMSCX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MMSCX | +0.6% | +4.9% | +6.4% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What MMSCX costs
On a $10,000 investment, MMSCX's 0.94% expense ratio costs about $94 a year. The prospectus estimates $1,619 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
MMSCX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | N/a | 19.15% |
| 2 | Flex Ltd | 0.54% |
| 3 | Credo Technology Group Holding Ltd | 0.52% |
| 4 | Revolution Medicines Inc | 0.49% |
| 5 | Carpenter Technology Corp | 0.49% |
| 6 | Natera Inc | 0.46% |
| 7 | Spx Technologies Inc | 0.45% |
| 8 | Littelfuse Inc | 0.44% |
| 9 | Jabil Inc | 0.43% |
| 10 | Franklin Resources Inc | 0.42% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 23.4% of the fund. See all top 25 holdings and asset mix →